Chile - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Chile Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 22.7% year on year. With 64 Cases in 2019, the country was ranked number 167 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 64.00 |
2018 | 62.00 |
2017 | 37.00 |
2016 | 30.00 |
2015 | 30.00 |
Download all data from 2005 to 2019
How does Chile rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
167 |
#167
Burundi
|
64 | 2019 | +28.0 % | +5.9 % | View data | |
167 |
#167
Chile
|
64 | 2019 | +3.2 % | +22.7 % | View data | |
170 |
#170
Gabon
|
63 | 2019 | -28.4 % | +1.3 % | View data |